Who
Amir Elstein
Director
Company insider
Files Form 4 as: Director, Tower Semiconductor; Director, Teva Pharmaceutical Industries.
In numbers
- Trades disclosed
- 36
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 5 Jun 2018
- Last trade
- 2 Jul 2026
- Last filed
- 6 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jul 2026filed 6 Jul 2026 | TSEM Tower SemiconductorSemiconductors | SEC FORM 4 Code A | —1,222 at $0.00 | filing |
| 2 Jul 2026filed 6 Jul 2026 | TSEM Tower SemiconductorSemiconductors | SEC FORM 4 Code A | —1,222 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | TEVA Teva Pharmaceutical IndustriesPharmaceuticals | SEC FORM 4 Code M | —14,492 | filing |
| 5 Jun 2026filed 8 Jun 2026 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —14,492 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —14,492 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | TEVA Teva Pharmaceutical IndustriesPharmaceuticals | SEC FORM 4 Code M | —14,492 | filing |
| 28 May 2026filed 1 Jun 2026 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —7,242 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —7,242 at $0.00 | filing |
| 6 Jun 2025filed 9 Jun 2025 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —9,632 at $0.00 | filing |
| 6 Jun 2025filed 9 Jun 2025 | TEVA Teva Pharmaceutical IndustriesPharmaceuticals | SEC FORM 4 Code M | —9,632 | filing |
| 5 Jun 2025filed 9 Jun 2025 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —14,492 at $0.00 | filing |
| 15 Jun 2024filed 17 Jun 2024 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —21,108 at $0.00 | filing |
| 15 Jun 2024filed 17 Jun 2024 | TEVA Teva Pharmaceutical IndustriesPharmaceuticals | SEC FORM 4 Code M | —21,108 | filing |
| 6 Jun 2024filed 10 Jun 2024 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —9,632 at $0.00 | filing |
| 4 Aug 2023filed 7 Aug 2023 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —15,810 at $0.00 | filing |
| 4 Aug 2023filed 7 Aug 2023 | TEVA Teva Pharmaceutical IndustriesPharmaceuticals | SEC FORM 4 Code M | —15,810 | filing |
| 15 Jun 2023filed 20 Jun 2023 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —21,108 at $0.00 | filing |
| 4 Aug 2022filed 8 Aug 2022 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —15,810 at $0.00 | filing |
| 14 Jun 2022filed 16 Jun 2022 | TEVA Teva Pharmaceutical Industriesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —14,479 at $0.00 | filing |
| 14 Jun 2022filed 16 Jun 2022 | TEVA Teva Pharmaceutical IndustriesPharmaceuticals | SEC FORM 4 Code M | —14,479 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.